{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:21:38Z","timestamp":1789687298230,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"crossref","award":["2016-I2M-2-001"],"award-info":[{"award-number":["2016-I2M-2-001"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"crossref","award":["3332018029"],"award-info":[{"award-number":["3332018029"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"crossref","award":["2018- I2M-3-001"],"award-info":[{"award-number":["2018- I2M-3-001"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Interdiscip Sci Comput Life Sci"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12539-019-00333-y","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T05:02:32Z","timestamp":1561957352000},"page":"300-306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Quantitative and Visual Characteristics of Primary Central Nervous System Lymphoma on 18F-FDG-PET"],"prefix":"10.1007","volume":"11","author":[{"given":"Delin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziren","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuekun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7836-8724","authenticated-orcid":false,"given":"Xin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"issue":"5","key":"333_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1634\/theoncologist.2008-0236","volume":"14","author":"M Sierra del Rio","year":"2009","unstructured":"Sierra del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K (2009) Primary CNS lymphoma in immunocompetent patients. Oncologist 14(5):526\u2013539. \n                    https:\/\/doi.org\/10.1634\/theoncologist.2008-0236","journal-title":"Oncologist"},{"issue":"sup1","key":"333_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/10428190802311441","volume":"49","author":"J Rubenstein","year":"2008","unstructured":"Rubenstein J, Ferreri AJM, Pittaluga S (2008) Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment. Leuk Lymphoma 49(sup1):43\u201351. \n                    https:\/\/doi.org\/10.1080\/10428190802311441","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"333_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1023\/A:1008201717089","volume":"8","author":"M Reni","year":"1997","unstructured":"Reni M, Ferreri AJM, Garancini MP, Villa E (1997) Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. Ann Oncol 8(3):227\u2013234. \n                    https:\/\/doi.org\/10.1023\/A:1008201717089","journal-title":"Ann Oncol"},{"issue":"11","key":"333_CR4","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1043\/2F1543-2165-132.11.1830","volume":"132","author":"S Bhagavathi","year":"2008","unstructured":"Bhagavathi S, Wilson J (2008) Primary central nervous system lymphoma. Arch Pathol Lab Med 132(11):1830\u20131834. \n                    https:\/\/doi.org\/10.1043\/2F1543-2165-132.11.1830","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"333_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1148\/radiol.2231010594","volume":"223","author":"S Cha","year":"2002","unstructured":"Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223(1):11\u201329. \n                    https:\/\/doi.org\/10.1148\/radiol.2231010594","journal-title":"Radiology"},{"issue":"3","key":"333_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3174\/ajnr.A2333","volume":"32","author":"S Wang","year":"2011","unstructured":"Wang S, Kim S, Chawla S, Wolf RL, Knipp DE, Vossough A, Melhem ER (2011) Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. Am J Neuroradiol 32(3):507\u2013514. \n                    https:\/\/doi.org\/10.3174\/ajnr.A2333","journal-title":"Am J Neuroradiol"},{"issue":"9","key":"333_CR7","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3174\/ajnr.A2161","volume":"31","author":"JH Ma","year":"2010","unstructured":"Ma JH, Kim HS, Rim NJ, Kim SH, Cho KG (2010) Differentiation among glioblastoma multiforme, solitary metastatic tumor, and lymphoma using whole-tumor histogram analysis of the normalized cerebral blood volume in enhancing and perienhancing lesions. Am J Neuroradiol 31(9):1699\u20131706. \n                    https:\/\/doi.org\/10.3174\/ajnr.A2161","journal-title":"Am J Neuroradiol"},{"issue":"2","key":"333_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1148\/radiol.2512072071","volume":"251","author":"DS Kim","year":"2009","unstructured":"Kim DS, Na DG, Kim KH, Kim J, Kim E, Yun B La, Chang K-H (2009) Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging. Radiology 251(2):467\u2013475. \n                    https:\/\/doi.org\/10.1148\/radiol.2512072071","journal-title":"Radiology"},{"issue":"3","key":"333_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10072-018-3669-7","volume":"40","author":"G Cheng","year":"2019","unstructured":"Cheng G, Zhang J (2019) Imaging features (CT, MRI, MRS, and PET\/CT) of primary central nervous system lymphoma in immunocompetent patients. Neurol Sci 40(3):535\u2013542. \n                    https:\/\/doi.org\/10.1007\/s10072-018-3669-7","journal-title":"Neurol Sci"},{"issue":"6","key":"333_CR10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12149-011-0483-1","volume":"25","author":"K Makino","year":"2011","unstructured":"Makino K, Hirai T, Nakamura H, Murakami R, Kitajima M, Shigematsu Y, Kuratsu JI (2011) Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study. Ann Nucl Med 25(6):432\u2013438. \n                    https:\/\/doi.org\/10.1007\/s12149-011-0483-1","journal-title":"Ann Nucl Med"},{"issue":"6","key":"333_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2214\/AJR.07.2660","volume":"190","author":"N Kosaka","year":"2008","unstructured":"Kosaka N, Tsuchida T, Uematsu H, Kimura H, Okazawa H, Itoh H (2008) 18F-FDG PET of common enhancing malignant brain tumors. Am J Roentgenol 190(6):365\u2013369. \n                    https:\/\/doi.org\/10.2214\/AJR.07.2660","journal-title":"Am J Roentgenol"},{"issue":"5","key":"333_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12149-010-0356-z","volume":"24","author":"N Kawai","year":"2010","unstructured":"Kawai N, Okubo S, Miyake K, Maeda Y, Yamamoto Y, Nishiyama Y, Tamiya T (2010) Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings. Ann Nucl Med 24(5):335\u2013343. \n                    https:\/\/doi.org\/10.1007\/s12149-010-0356-z","journal-title":"Ann Nucl Med"},{"issue":"10\u201311","key":"333_CR13","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0042-6989(00)00262-5","volume":"41","author":"AA Lammertsma","year":"2001","unstructured":"Lammertsma AA (2001) PET\/SPECT: functional imaging beyond flow. Vis Res 41(10\u201311):1277\u20131281. \n                    https:\/\/doi.org\/10.1016\/S0042-6989(00)00262-5","journal-title":"Vis Res"},{"issue":"2","key":"333_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2478\/raon-2013-0016","volume":"47","author":"S Maza","year":"2013","unstructured":"Maza S, Buchert R, Brenner W, Munz DL, Thiel E, Korfel A, Kiewe P (2013) Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma. Radiol Oncol 47(2):103\u2013110. \n                    https:\/\/doi.org\/10.2478\/raon-2013-0016","journal-title":"Radiol Oncol"},{"issue":"2","key":"333_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11060-004-3390-7","volume":"72","author":"W K\u00fcker","year":"2005","unstructured":"K\u00fcker W, N\u00e4gele T, Korfel A, Heckl S, Thiel E, Bamberg M, Herrlinger U (2005) Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol 72(2):169\u2013177. \n                    https:\/\/doi.org\/10.1007\/s11060-004-3390-7","journal-title":"J Neurooncol"},{"issue":"2","key":"333_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11060-010-0182-0","volume":"100","author":"N Kawai","year":"2010","unstructured":"Kawai N, Zhen HN, Miyake K, Yamamaoto Y, Nishiyama Y, Tamiya T (2010) Prognostic value of pretreatment18F-FDG PET in patients with primary central nervous system lymphoma: SUV-based assessment. J Neurooncol 100(2):225\u2013232. \n                    https:\/\/doi.org\/10.1007\/s11060-010-0182-0","journal-title":"J Neurooncol"},{"issue":"2","key":"333_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1215\/15228517-2007-061","volume":"10","author":"NA Mohile","year":"2008","unstructured":"Mohile NA, DeAngelis LM, Abrey LE (2008) The utility of body FDG PET in staging primary central nervous system lymphoma. Neuro-Oncology 10(2):223\u2013228. \n                    https:\/\/doi.org\/10.1215\/15228517-2007-061","journal-title":"Neuro-Oncology"},{"issue":"2","key":"333_CR18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00259-005-1917-6","volume":"33","author":"H Palmedo","year":"2006","unstructured":"Palmedo H, Urbach H, Bender H, Schlegel U, Schmidt-Wolf IGH, Matthies A, Pels H (2006) FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up. Eur J Nucl Med Mol Imaging 33(2):164\u2013168. \n                    https:\/\/doi.org\/10.1007\/s00259-005-1917-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"333_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s12149-014-0851-8","volume":"28","author":"S Yamaguchi","year":"2014","unstructured":"Yamaguchi S, Hirata K, Kobayashi H, Shiga T, Manabe O, Kobayashi K, Houkin K (2014) The diagnostic role of 18F-FDG PET for primary central nervous system lymphoma. Ann Nucl Med 28(7):603\u2013609. \n                    https:\/\/doi.org\/10.1007\/s12149-014-0851-8","journal-title":"Ann Nucl Med"},{"issue":"11","key":"333_CR20","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/MNM.0b013e328264ae7f","volume":"28","author":"D Karantanis","year":"2007","unstructured":"Karantanis D, O\u02bcNeill BP, Subramaniam RM, Witte RJ, Mullan BP, Nathan MA, Wiseman GA (2007) 18F-FDG PET\/CT in primary central nervous system lymphoma in HIV-negative patients. Nucl Med Commun 28(11):834\u2013841. \n                    https:\/\/doi.org\/10.1097\/MNM.0b013e328264ae7f","journal-title":"Nucl Med Commun"},{"issue":"March","key":"333_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejrad.2018.04.020","volume":"104","author":"W Zhou","year":"2018","unstructured":"Zhou W, Wen J, Hua F, Xu W, Lu X, Yin B, Guan Y (2018) 18F-FDG PET\/CT in immunocompetent patients with primary central nervous system lymphoma: differentiation from glioblastoma and correlation with DWI. Eur J Radiol 104(March):26\u201332. \n                    https:\/\/doi.org\/10.1016\/j.ejrad.2018.04.020","journal-title":"Eur J Radiol"},{"issue":"2","key":"333_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00701-014-2290-7","volume":"157","author":"S Yamaguchi","year":"2015","unstructured":"Yamaguchi S, Hirata K, Kaneko S, Kobayashi H, Shiga T, Kobayashi K, Houkin K (2015) Combined use of 18\u00a0F-FDG PET and corticosteroid for diagnosis of deep-seated primary central nervous system lymphoma without histopathological confirmation. Acta Neurochir 157(2):187\u2013194. \n                    https:\/\/doi.org\/10.1007\/s00701-014-2290-7","journal-title":"Acta Neurochir"},{"issue":"2","key":"333_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2478\/raon-2013-0016","volume":"47","author":"S Maza","year":"2013","unstructured":"Maza S, Buchert R, Brenner W, Munz DL, Thiel E, Korfel A, Kiewe P (2013) Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma. Radiol Oncol 47(2):103\u2013110. \n                    https:\/\/doi.org\/10.2478\/raon-2013-0016","journal-title":"Radiol Oncol"},{"issue":"19","key":"333_CR24","doi-asserted-by":"publisher","first-page":"e6676","DOI":"10.1097\/MD.0000000000006676","volume":"96","author":"M Yang","year":"2017","unstructured":"Yang M, Sun J, Bai HX, Tao Y, Tang X, States LJ, Yang L (2017) Diagnostic accuracy of SPECT, PET, and MRS for primary central nervous system lymphoma in HIV patients. Medicine 96(19):e6676. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000006676","journal-title":"Medicine"},{"issue":"3\u20134","key":"333_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/10428199509107892","volume":"19","author":"M Krough-Jensen","year":"1995","unstructured":"Krough-Jensen M, Amore FD, Jensen MK, Christensen BE, Thorling K, Pedersen M, Andersen E (1995) Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area; Population-B. Leuk Lymphoma 19(3\u20134):223\u2013233. \n                    https:\/\/doi.org\/10.3109\/10428199509107892","journal-title":"Leuk Lymphoma"}],"container-title":["Interdisciplinary Sciences: Computational Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12539-019-00333-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12539-019-00333-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12539-019-00333-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T23:24:30Z","timestamp":1593473070000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12539-019-00333-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["333"],"URL":"https:\/\/doi.org\/10.1007\/s12539-019-00333-y","relation":{},"ISSN":["1913-2751","1867-1462"],"issn-type":[{"value":"1913-2751","type":"print"},{"value":"1867-1462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"4 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest regarding the publication of paper. The authors thank American Journal Experts for providing language help.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}